O verlap with symptoms arising from functional upper gastrointestinal disorders frequently poses challenges for a confident symptom-based diagnosis of gastroesophageal reflux disease (GERD). [1] [2] [3] As single tests for GERD, both endoscopy and esophageal pH monitoring have limitations in terms of sensitivity, and no agreed gold standard diagnostic test exists for GERD. 2, 4 Esophageal endoscopy and esophageal pH recording with symptom-acid reflux association monitoring together provide the best available objective reference standard for diagnosis. 5 Nevertheless, this reference standard of combined investigations cannot be considered a gold standard, nor is it practical for routine management. Relatively simple tests that enhance the accuracy of GERD diagnosis and are suitable for routine clinical practice are needed, especially for patients with reflux disease who do not have visible esophageal erosions or ulceration on routine endoscopy, and in settings in which pH monitoring is not widely available.
Only a few research groups have developed systems of grading histologic parameters of the distal esophageal mucosa in individuals with GERD, [6] [7] [8] [9] [10] [11] and the potential clinical utility of such parameters in disease diagnosis is still far from having been adequately tested. Precise definitions for histologic criteria, including basal cell hyperplasia and papillary elongation, were developed and refined by an international working group. 12, 13 The assessments of this group showed promising levels of interassessor agreement on diagnostic criteria for refluxinduced nonerosive mucosal damage to the esophagus. 13 Until now, the correlation of these histologic criteria with clinical variables, such as esophageal acid exposure and reflux esophagitis at endoscopy, has not been systematically assessed. The aim of the current analysis was to evaluate the accuracy of these criteria for the diagnosis of GERD, as defined by endoscopy and pH monitoring, and to measure interassessor agreement on histologic criteria. This analysis was carried out in a wellcharacterized primary care population with troublesome upper gastrointestinal symptoms, which is the population most relevant to this type of testing.
Materials and Methods

Study Design
Histologic markers for GERD were assessed using lower esophageal biopsies from patients in the Diamond study (ClinicalTrials.gov Identifier: NCT00291746). 5 The Diamond study was conducted in Denmark, Germany, Norway, Sweden, the United Kingdom, and Canada, and recruited primary care patients aged 17-79 years who presented with frequent upper gastrointestinal symptoms. 5 The Diamond study enrolled 507 patients, of whom 308 were fully suitable for the primary analysis 5 and 336 were evaluable for post hoc exploratory analyses. 3, 14 
Study Population
Individuals were included in the study if they had not taken a proton pump inhibitor in the previous 2 months, and had experienced upper gastrointestinal symptoms of any severity (from very mild to severe) on 2 or more days per week for at least 4 weeks before the start of the study, and symptoms of at least mild severity on 3 or more days during the 7 days before study entry. 5 Use of histamine 2 receptor antagonists was not allowed during the study period.
Major exclusion criteria were upper gastrointestinal endoscopy during the year before the study; previous antireflux surgery, surgery for a peptic ulcer, or other gastrointestinal resection; daily use of acetylsalicylic acid (>165 mg/day) or nonsteroidal anti-inflammatory drugs (any dose); and alert features (eg, dysphagia, weight loss, anemia). 5 
Study Investigations
Reflux esophagitis was assessed using standard upper gastrointestinal endoscopy, and was graded according to the Los Angeles classification. 15 Esophageal biopsies were taken from 0.5 cm and 2.0 cm above the Z line in the 3-o'clock position, which has been shown previously to be the radial position in which erosions are most predominantly visualized. 16 If mucosal breaks were visible at either of these locations, biopsies were taken from unbroken squamous epithelium 1 cm lateral from the edge of the mucosal break but at the same height above the Z line.
Following endoscopy, esophageal acid exposure and acid reflux episodes were measured using a wireless pHmonitoring capsule (Given Imaging, Yokne'am Illit, Israel). Esophageal acid exposure was analyzed for 24 hours from midnight on the day the pH capsule was placed, to standardize the time window for pH data analysis. The symptom-acid association probability 17 was determined over 24 hours from midnight on the day the pH capsule was placed.
Histologic Assessments
Biopsy specimens were fixed, processed in an increasing series of alcohol and xylol, and embedded in paraffin. Serial sectioning into 4-mm-thick slices and staining with H&E were performed after deparaffinization. Evaluable biopsies were analyzed independently by assessors at 2 pathology centers (Bayreuth, Germany and Genoa, Italy). Recent consensus guidelines for the histologic recognition of microscopic esophagitis were used. 12, 13 The histologic variables assessed included total epithelial thickness, basal cell layer thickness, and papillary length (all in micrometers); presence of dilated intercellular spaces (severity score, 0-2); and number of inflammatory cells. Each variable was assessed in the most affected area of the specimen. Total epithelial thickness was measured in 2 areas of each biopsy: the site at which basal cell layer thickness was evaluated and the site at which papillary length was evaluated.
Diagnostic Criteria
Gastroesophageal reflux disease. Investigationdefined GERD was identified when 1 or more of the following was present: (1) reflux esophagitis on endoscopy (Los Angeles classification grades A-D), (2) pathologic distal esophageal acid exposure (esophageal pH <4 for >5.5% of the time during the 24-hour monitoring period), and (3) positive symptom-acid association probability (!95%) for association of symptoms with acid.
Nonerosive reflux disease. Nonerosive reflux disease was defined as the presence of pathologic esophageal acid exposure and/or a positive symptom-acid association probability on investigation, but with no reflux esophagitis on endoscopy.
Control group. The control group consisted of all patients without investigation-defined GERD unless otherwise indicated. All individuals in the control group had frequent upper gastrointestinal symptoms, in accordance with study inclusion criteria.
Statistical Analyses
For each histologic variable, univariate logistic regression analysis was used to model the probability of having investigation-defined GERD, based on data from center 1, to assess which parameter was the most representative of a clinical diagnosis of GERD. Cutoff values for the sensitivity, specificity, and positive and negative predictive power of each histologic variable were calculated, and receiver operating characteristic curves were generated. The best cutoff value for each variable was defined as that with the highest efficiency value, calculated as the sum of the number of positive results in patients with investigation-defined GERD and the number of negative results in patients without investigation-defined GERD.
Potential cutoff values were assessed in 10-mm increments (starting from 0 mm) for total epithelial thickness and papillary length, and in increments of 1 (starting from 0) for the number of eosinophils.
Exploratory analyses using backward stepwise multivariate logistic regression were conducted to model the probability of identifying investigation-defined GERD based on the presence of histologic features at 0.5 cm and 2.0 cm above the Z line. The best model was selected based on the comparison of the area under the curve (AUC) for the receiver operating characteristic. Continuous variables were summarized by descriptive statistics (means and 95% confidence intervals) and categorical variables by frequency counts and percentages.
Discriminant analyses (error rates and estimated differences) and correlation analyses (Pearson correlation coefficients) were performed on the independent readings from the 2 pathology centers.
Results
Diagnoses
Of the 507 patients enrolled in the Diamond study, data from 336 were suitable for exploratory analyses, 59% of whom had GERD. Our post hoc histology analyses were based on biopsies from 258 patients who were deemed evaluable (77% of all biopsies) at pathology center 1 (Bayreuth, Germany) and 195 patients considered evaluable (58% of all biopsies) at pathology center 2 (Genoa, Italy). The reasons for biopsies being classified as nonevaluable included technical reasons (main reason), mostly caused by incorrect orientation of the sample; mislabeling; poor-quality samples; missing samples; or samples taken from the wrong quadrant. Overall, 53% (138 of 258) of evaluable biopsies analyzed at center 1 and 60% (117 of 195) of those analyzed at center 2 originated from patients who met diagnostic criteria for investigation-defined GERD. The biopsied group was representative of the entire study population with regard to the proportion of individuals with investigation-defined GERD (which was 59% [197 of 336] in the entire study population 14 ) . The distribution of diagnostic criteria in biopsies from patients with GERD (center 1) is shown in Supplementary Table 1 .
Descriptive Statistics
Mean total epithelial thickness (measured at the assessment site for basal cell layer thickness and papillary length) and papillary length, measured at 0.5 cm and 2.0 cm above the Z line, were significantly greater in patients with investigation-defined GERD than in those without investigation-defined GERD ( Table 1 ).
Probability of Investigation-Defined Gastroesophageal Reflux Disease by Histologic Variable
Total epithelial thickness (at assessment sites for basal cell layer thickness and for papillary length) and papillary length were predictive of investigation-defined GERD (P < .05 on logistic regression) both at 0.5 cm and 2.0 cm above the Z line (Supplementary Table 2 ). Presence of eosinophils at 2.0 cm above the Z line was also predictive of investigation-defined GERD. Basal cell layer thickness and presence of dilated intercellular spaces were not predictive of GERD. The results of each univariate logistic regression analysis should be interpreted with some caution, however, because the models had AUCs just below 0.7.
The cutoff that yielded the highest efficiency value was at least 430 mm for total epithelial thickness measured at the assessment site for basal cell layer thickness and at least 320 mm for papillary length, both measured at 2.0 cm above the Z line. The resulting specificity/sensitivity values for investigation-defined GERD were 75.8%/47.8% and 87.5%/34.8%, respectively, for total epithelial thickness and papillary length (Table 2, Figure 1 ). Presence of 1 or more eosinophils at 2.0 cm above the Z line had high specificity (!98%) but low sensitivity ( 12%) for investigation-defined GERD.
Of 258 biopsies from 2.0 cm above the Z line evaluated at center 1, a total of 89 had a total epithelial thickness of at least 430 mm when measured at the assessment site for basal cell layer thickness. The proportion of patients with total epithelial thickness of at least 430 mm at 2.0 cm above the Z line was 43% (83 of 195) among the group with investigation-defined GERD and 10% (6 of 63) in the group without investigationdefined GERD.
Total epithelial thickness at both the assessment sites for basal cell layer thickness and papillary length, and papillary length were predictive (P < .05) of reflux esophagitis and pathologic esophageal acid exposure, both at 0.5 cm and 2.0 cm above the Z line ( Table 3 ).
Probability of Nonerosive Reflux Disease by Histologic Variable
Total epithelial thickness was predictive of nonerosive reflux disease when measured at 0.5 cm and 2.0 cm above the Z line at the assessment site for basal cell layer thickness, and when measured at 0.5 cm above the Z line at the assessment site for papillary length (Table 4 ).
Multivariate Analyses
Multivariate logistic regression analysis revealed that total epithelial thickness measured at the assessment site for basal cell layer thickness was significantly different in individuals with investigation-defined GERD than in those without, both at 0.5 cm and 2.0 cm above the Z line ( Figure 2 ). The interpretation of this significant covariate should be drawn with some caution, however, because the model has an AUC just below 0.7 (Figure 2 ).
Interassessor Agreement
The independent assessors at the 2 centers were in agreement (P > .05) regarding measurements of total epithelial thickness at the assessment site for basal cell layer thickness, and also for basal cell layer thickness, both at 0.5 cm and at 2.0 cm above the Z line (results not shown). The following were confirmed as significant predictors of investigation-defined GERD (P < .05) by assessments at 2 independent centers: total epithelial thickness (sites for basal cell layer thickness and for papillary length) 2.0 cm above the Z line and papillary length 2.0 cm above the Z line (Table 4 ).
Discussion
The most important result of this study, conducted in primary care patients presenting with frequent upper gastrointestinal symptoms, is that total epithelial thickness of the distal esophageal mucosa was found to be the most robust histologic marker for not only the whole group with investigation-defined GERD, but also for the subgroup of patients with nonerosive reflux disease, which is the important diagnostic challenge. When measured at 0.5 cm or 2.0 cm above the Z line, total epithelial thickness was a significant predictor of the presence of investigation-defined GERD, reflux esophagitis, pathologic esophageal acid exposure, and nonerosive reflux disease. Total epithelial thickness was confirmed as a significant covariate in multivariate logistic regression analysis, although interpretations should be made with caution because of the model's AUC of just below 0.7. Analyses from 2 independent readings also supported total epithelial thickness at the assessment site for basal cell layer thickness as a robust histologic marker for GERD. These findings are promising for clinical practice because, provided that the gastroesophageal junction is accurately identified, they suggest that evaluation of 1 relatively easily assessed and standardized histologic marker can improve recognition of GERD when endoscopy shows no erosions. This measure may also be useful when pH testing is not available.
Of studies that have assessed histologic variables in patients with and without GERD, several have reported increased basal cell layer thickness and papillary length as a percentage of total epithelial thickness, but none seems to have assessed whether total epithelial thickness as an absolute value can be used as an indicator of refluxinduced esophageal epithelial hyperplasia. 7, 8, 10, 12, 13, 18 In the present study, papillary length was predictive of GERD in the overall patient population, more than half of whom had reflux esophagitis, but it did not predict the presence of reflux disease in the subgroup without endoscopically recognizable esophagitis. The relatively low value of papillary length as a generally applicable diagnostic criterion is reinforced by the fact that assessments performed at the 2 centers had no significant agreement regarding detection of this variable, presumably because it is difficult to assess. 6 The presence of eosinophils was highly predictive of investigation-defined GERD, but had low sensitivity ( 12%). The lack of predictive power of dilated intercellular spaces for GERD in our primary care population was surprising, especially because it has been reported previously as a promising candidate histologic marker for the disease. 6 A reason for this may be that the consistent assessment of intercellular space dilation is more challenging than that of total epithelial thickness, even with well-validated criteria. 13 Although several studies have compared histologic variables in patients with nonerosive reflux disease with those in symptom-free control subjects, 7, 8, [19] [20] [21] [22] [23] ours is the first study to use patients with frequent, troublesome upper gastrointestinal symptoms as the control group. Such a control group has most relevance in clinical practice, in which the challenge is often to differentiate between upper gastrointestinal symptoms that are due to GERD and those that are due to functional disorders. This difference in the control groups between the present study and previous studies may also explain why we found that basal cell layer thickness and presence of dilated intercellular spaces lacked predictive power for GERD and nonerosive reflux disease, whereas several other studies using asymptomatic control subjects observed marked numerical differences in the prevalence of these markers between patients with nonerosive reflux disease and asymptomatic control subjects. 7, 8, [19] [20] [21] [22] [23] The discrepant results suggest that basal cell hyperplasia and dilated intercellular spaces may be more prevalent in individuals without GERD but with frequent upper gastrointestinal symptoms than in asymptomatic control subjects, rather than being specific for GERD.
An epithelial thickness of 430 mm or greater (measured at 2.0 cm above the Z line) was found to be the best cutoff between normality and thickened mucosa. The reproducibility of total epithelial thickness as a predictor of investigation-defined GERD is likely to be due, at least in part, to its constancy within a biopsy specimen. The start of the basal layer and the surface of the epithelium are easyto-define landmarks compared with the top of the basal layer or the papillae. Increased total epithelial thickness was a more robust marker when measured at the assessment site for basal cell layer thickness than at the site for total papillary length. The reason for this discrepancy may be that basal cell layer thickness is usually measured perpendicular to the basal membrane (thus giving reproducible results), whereas the measured thickness of the epithelium at the papillary site depends on the angle of the papilla that is being measured (thus providing more variable results because, quite often, biopsy specimens are not perfectly oriented). Measuring histologic parameters in micrometers is time-consuming, which is why many studies that include assessment of histologic criteria use a semi-quantitative assessment scoring of conventional parameters. 7, 8, 24, 25 When reported as an absolute value (in micrometers), however, total epithelial thickness requires just 1 measurement, compared with at least 2 measurements (and the need to calculate a ratio) for papillary length or basal cell layer thickness, which are reported as proportions of total epithelial thickness. Differences between centers 1 and 2 in our study can be explained by the well-known variability in morphological analyses. The differences are smaller than might be anticipated. 13 Our study included a relatively large, well-defined patient population that should be representative of patients seen in primary care. Well-validated criteria were used for the assessment of histologic changes; however, because the cutoff values for histologic criteria were established and assessed in our patient population, their utility still needs to be tested and validated in a different group of patients. A limitation of our study is that a proportion of the biopsy specimens was not assessable; however, the proportion of patients with investigationdefined GERD was similar in the groups with and without assessable specimens, showing that the biopsied group was representative of the entire study population.
In conclusion, total epithelial thickness in the noneroded distal esophagus was found to be a robust histologic marker for investigation-defined GERD that has the potential for clinical applicability both in and outside of specialist centers. This parameter may prove useful as a surrogate marker of esophageal injury related to GERD, allowing identification of patients with nonerosive reflux disease and assessment of efficacy of treatments in this patient group. The success of total epithelial thickness on its own as a predictor for GERD and its subgroups suggests that there is potential for this parameter to be incorporated as an additional or alternative marker in endoscopic biopsy assessments in clinical practice. NOTE. Center 1, N ¼ 258 (patients with investigation-defined GERD, n ¼ 138; without, n ¼ 120). SAP, symptom-acid association probability. 
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